NASDAQ:PCRX

Pacira Pharmaceuticals Stock Insider Trading

etoro logo Buy PCRX
*Your capital is at risk
$22.32
+0.0700 (+0.315%)
At Close: Jun 03, 2026

Pacira Pharmaceuticals Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -2.60. In total, the insiders bought 2.16B and sold 25.9M PCRX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-2.60
Buy 2.16B shares
Sell 25.9M shares
63% Buy Activity
Weak Negative Correlation
Buy Signal Low Confidence
Feb 11, 2026

Analysis Breakdown:

  • Weakened by a contradictory negative Insider Power Score.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jun 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Kronenfeld Mark A.
Director
Director 11 279
Value: $274.5K
Jun 11, 2025
Buy
Common Stock
A-Award
Ceesay Abraham
Director
Director 6 163
Value: $150.0K
Jun 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Ceesay Abraham
Director
Director 11 279
Value: $274.5K
Jun 11, 2025
Buy
Common Stock
A-Award
Froimson Mark
Director
Director 6 163
Value: $150.0K
Jun 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Froimson Mark
Director
Director 11 279
Value: $274.5K
Jun 11, 2025
Buy
Common Stock
A-Award
Bigal Marcelo
Director
Director 6 163
Value: $150.0K
Jun 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Bigal Marcelo
Director
Director 11 279
Value: $274.5K
Jun 11, 2025
Buy
Common Stock
A-Award
Yang Michael J.
Director
Director 6 163
Value: $150.0K
Jun 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Yang Michael J.
Director
Director 11 279
Value: $274.5K
Jun 11, 2025
Buy
Common Stock
A-Award
Christie Christopher
Director
Director 6 163
Value: $150.0K
Jun 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Christie Christopher
Director
Director 11 279
Value: $274.5K
Jun 11, 2025
Buy
Common Stock
A-Award
Young Alethia
Director
Director 6 163
Value: $150.0K
Jun 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Young Alethia
Director
Director 11 279
Value: $274.5K
Jun 11, 2025
Buy
Common Stock
A-Award
Brege Laura
Director
Director 6 163
Value: $150.0K
Jun 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Brege Laura
Director
Director 11 279
Value: $274.5K
Jun 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Brege Laura
Director
Director 11 279
Value: $274.5K
Jun 11, 2025
Buy
Common Stock
A-Award
Brege Laura
Director
Director 6 163
Value: $150.0K
Jun 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Young Alethia
Director
Director 11 279
Value: $274.5K
Jun 11, 2025
Buy
Common Stock
A-Award
Young Alethia
Director
Director 6 163
Value: $150.0K
Jun 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Christie Christopher
Director
Director 11 279
Value: $274.5K
Jun 11, 2025
Buy
Common Stock
A-Award
Christie Christopher
Director
Director 6 163
Value: $150.0K
Jun 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Yang Michael J.
Director
Director 11 279
Value: $274.5K
Jun 11, 2025
Buy
Common Stock
A-Award
Yang Michael J.
Director
Director 6 163
Value: $150.0K
Jun 11, 2025
Buy
Stock Option (Right to Buy)
A-Award
Bigal Marcelo
Director
Director 11 279
Value: $274.5K
Jun 11, 2025
Buy
Common Stock
A-Award
Froimson Mark
Director
Director 6 163
Value: $150.0K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PACIRA PHARMACEUTICALS
Pacira Pharmaceuticals
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted ner...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE